Concepedia

Author

Giuseppe Andò

University of MessinaORCID

Also Known As

Agostino Gnasso, Andò, Giuseppe, Corrado Tamburino, F Manca, G ANDO, G Ando, G Ando', G Ando’, G Andò, G Oreto

308

Publications

6.6K

Citations

38

H-Index

54

Concepts

All Affiliations

University of MessinaUniversity of Naples Federico IIAzienda Ospedaliera Universitaria Policlinico "G. Martino"University of Campania "Luigi Vanvitelli"Policlinico San Matteo Fondazione
GA

About

Giuseppe Andò is an author at University of Messina specializing in cardiovascular disease, medicine, and cardiology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

15

20

2.6K

2

Emergency Medicine

8

10

2.3K

3

Public Health

6

6

1.5K

4

Health Sciences

1

1

41

5

Epidemiology

1

1

12

Giuseppe Andò

×

43

Publications

3.5K

Citations

25

H-Index

YearCitations

Radial versus femoral access in patients with acute coronary syndromes undergoing invasive management: a randomised multicentre trial

Marco Valgimigli, Andrea Gagnor, Paolo Calabrò,

The Lancet

2015

1.3K

Bivalirudin or Unfractionated Heparin in Acute Coronary Syndromes

Marco Valgimigli, Enrico Frigoli, Sergio Leonardi,

New England Journal of Medicine

2015

378

Radial versus femoral access and bivalirudin versus unfractionated heparin in invasively managed patients with acute coronary syndrome (MATRIX): final 1-year results of a multicentre, randomised controlled trial

Marco Valgimigli, Enrico Frigoli, Sergio Leonardi,

The Lancet

2018

289

Acute Kidney Injury After Radial or Femoral Access for Invasive Acute Coronary Syndrome Management

Giuseppe Andò, Bernardo Cortese, Filippo Russo,

Journal of the American College of Cardiology

2017

150

Prognostic Implications of Declining Hemoglobin Content in Patients Hospitalized With Acute Coronary Syndromes

Sergio Leonardi, Felice Gragnano, Greta Carrara,

Journal of the American College of Cardiology

2021

124

Timing of Oral P2Y12 Inhibitor Administration in Patients With Non-ST-Segment Elevation Acute Coronary Syndrome

Giuseppe Tarantini, Marco Mojoli, Ferdinando Varbella,

Journal of the American College of Cardiology

2020

104

Impact of clinical presentation on ischaemic and bleeding outcomes in patients receiving 6- or 24-month duration of dual-antiplatelet therapy after stent implantation: a pre-specified analysis from the PRODIGY (Prolonging Dual-Antiplatelet Treatment After Grading Stent-Induced Intimal Hyperplasia) trial

Francesco Costa, P Vranckx, Sergio Leonardi,

European Heart Journal

2015

85

Age, glomerular filtration rate, ejection fraction, and the AGEF score predict contrast‐induced nephropathy in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention

Giuseppe Andò, Gaetano Morabito, Cesare de Gregorio,

Catheterization and Cardiovascular Interventions

2013

83

Incremental Value of the CRUSADE, ACUITY, and HAS‐BLED Risk Scores for the Prediction of Hemorrhagic Events After Coronary Stent Implantation in Patients Undergoing Long or Short Duration of Dual Antiplatelet Therapy

Francesco Costa, Jan G.P. Tijssen, Sara Ariotti,

Journal of the American Heart Association

2015

76

Renal Function–Adjusted Contrast Volume Redefines the Baseline Estimation of Contrast-Induced Acute Kidney Injury Risk in Patients Undergoing Primary Percutaneous Coronary Intervention

Giuseppe Andò, Cesare de Gregorio, Gaetano Morabito,

Circulation Cardiovascular Interventions

2014

65

Page 1